 |
 |

Wait-and-See Prescription for Acute Otitis Media
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Spiro and colleagues1 reported the results of a trial of "wait-and-see prescription" (WASP) for treatment of acute otitis media. In an accompanying editorial, Dr Little2 stated that it would be unwise to use the WASP approach to antimicrobial therapy if a child with acute otitis media has already had high fever and severe otalgia for more than 72 hours.
However, Spiro et al did not use these as exclusionary criteria; in their study, patients were excluded only if they appeared "toxic," not based on height of fever or pretherapy symptom duration and severity. Little's implicit assumption that the subgroup identified by his criteria would fare poorly with expectant management, which may be correct, could be substantiated from Spiro et al if such patients were studied and they either (1) always had the prescription filled when randomized to the WASP group or (2) had significantly worse outcomes . . . [Full Text of this Article]
James R. Johnson, MD
johns007@umn.edu VA Medical Center Minneapolis, Minn
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED LETTERS
Wait-and-See Prescription for Acute Otitis MediaReply
Paul Little
JAMA. 2007;297(2):152.
EXTRACT
| FULL TEXT
Wait-and-See Prescription for Acute Otitis MediaReply
David M. Spiro and Eugene D. Shapiro
JAMA. 2007;297(2):152-153.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Wait-and-See Prescription for the Treatment of Acute Otitis Media: A Randomized Controlled Trial
David M. Spiro, Khoon-Yen Tay, Donald H. Arnold, James D. Dziura, Mark D. Baker, and Eugene D. Shapiro
JAMA. 2006;296(10):1235-1241.
ABSTRACT
| FULL TEXT
|